TBIO.OB Insider Trading Activity and SEC Form 4 Filings
TBIO.OB insider trading summary
No open-market insider purchases or sales of Transgenomic Inc (TBIO.OB) have been reported on SEC Form 4 in the past 12 months.
Latest TBIO.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 25, 2013 | Randal J Kirk | 10% Owner | Buy | $0 (1,200,000 @ $0.00) |
| Jan 25, 2013 | Randal J Kirk | 10% Owner | Buy | $0 (2,400,000 @ $0.00) |
| Jan 25, 2013 | Randal J Kirk | 10% Owner | Buy | $0 (2,400,000 @ $0.00) |
| Jun 15, 2012 | Chad M Richards | Chief Commercial Officer | Buy | $12K (14,750 @ $0.79) |
| Feb 3, 2012 | Robert Patzig | Director | Buy | $0 (25,000 @ $0.00) |
| Feb 3, 2012 | Doit Koppler II | Director | Buy | $0 (35,000 @ $0.00) |
| Jun 16, 2011 | Doit Koppler II | Director | Buy | $23K (15,000 @ $1.53) |
| Jun 15, 2011 | Robert Patzig | Director | Buy | $23K (15,000 @ $1.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.